Sale!

G6PC Gene Glycogen storage disease type 1A Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The G6PC gene glycogen storage disease type 1A genetic test is a specialized diagnostic procedure designed to detect mutations in the G6PC gene, which are responsible for causing glycogen storage disease type 1A (GSD1A). GSD1A is a rare genetic disorder that impairs the body’s ability to break down glycogen into glucose, leading to a variety of symptoms including low blood sugar levels, growth retardation, and accumulation of glycogen in the liver and kidneys, potentially causing organ damage.

This test is particularly important for individuals with a family history of GSD1A or those exhibiting symptoms suggestive of the disease. Early detection through genetic testing can facilitate prompt management and treatment strategies, significantly improving the quality of life and health outcomes for affected individuals.

Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves collecting a DNA sample, usually through a blood draw or cheek swab. The sample is then analyzed for specific mutations in the G6PC gene that confirm the diagnosis of GSD1A. The cost of the test is 4400 AED, reflecting the specialized technology and expertise required to accurately identify the genetic mutations associated with the condition.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

G6PC Gene Glycogen storage disease type 1A Genetic Test

Welcome to DNA Labs UAE, where we offer the G6PC Gene Glycogen storage disease type 1A Genetic Test. This test helps diagnose and provide information about the specific genetic changes responsible for Glycogen storage disease type 1A (GSD1A).

Test Details

The G6PC gene is responsible for producing an enzyme called glucose-6-phosphatase, which is crucial for breaking down glycogen into glucose in the liver. Mutations in the G6PC gene can lead to GSD1A, an autosomal recessive disorder characterized by the accumulation of glycogen in various tissues, particularly the liver and kidneys.

Individuals with GSD1A may experience symptoms such as hypoglycemia (low blood sugar), growth retardation, enlarged liver and kidneys, and an increased risk of developing osteoporosis and kidney stones.

Test Components and Price

  • Test Name: G6PC Gene Glycogen storage disease type 1A Genetic Test
  • Components: NGS Technology
  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Test Type: Metabolic Disorders
  • Doctor: General Physician
  • Test Department: Genetics

Pre Test Information

Prior to undergoing the G6PC Gene Glycogen storage disease type 1A Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected with GSD1A.

Method

The G6PC Gene Glycogen storage disease type 1A Genetic Test utilizes Next-Generation Sequencing (NGS) technology. This advanced genetic testing method allows for the simultaneous analysis of multiple genes, including the G6PC gene, to identify any mutations or variations associated with GSD1A.

Test Process

The G6PC Gene Glycogen storage disease type 1A Genetic Test can be performed using a blood or saliva sample. The DNA is then sequenced to identify any variations or mutations in the G6PC gene.

Benefits of the Test

By confirming a diagnosis of GSD1A and providing information about the specific genetic changes responsible for the condition, the test results can help guide treatment and management strategies. Additionally, the results can provide information about the likelihood of passing on the condition to future generations.

At DNA Labs UAE, we are committed to providing accurate and reliable genetic testing services. Contact us today to schedule the G6PC Gene Glycogen storage disease type 1A Genetic Test and gain valuable insights into your health.

Test Name G6PC Gene Glycogen storage disease type 1A Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Metabolic Disorders
Doctor General Physician
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for G6PC Gene Glycogen storage disease type 1A NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Glycogen storage disease type 1A
Test Details

The G6PC gene is responsible for producing an enzyme called glucose-6-phosphatase, which plays a crucial role in the breakdown of glycogen into glucose in the liver. Mutations in the G6PC gene can lead to a condition called glycogen storage disease type 1A (GSD1A).

GSD1A is an autosomal recessive disorder characterized by the accumulation of glycogen in various tissues, particularly the liver and kidneys. This buildup of glycogen impairs the body’s ability to regulate blood sugar levels, leading to symptoms such as hypoglycemia (low blood sugar), growth retardation, enlarged liver and kidneys, and an increased risk of developing osteoporosis and kidney stones.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes, including the G6PC gene, in order to identify any mutations or variations that may be associated with GSD1A. This type of testing can help confirm a diagnosis of GSD1A and provide information about the specific genetic changes responsible for the condition.

NGS genetic testing can be performed using a blood or saliva sample and involves sequencing the DNA to identify any variations or mutations in the G6PC gene. The results of the test can help guide treatment and management strategies for individuals with GSD1A, as well as provide information about the likelihood of passing on the condition to future generations.